Webcast - ASCO Direct™ Highlights: 2021 Official Annual Meeting Review
This accredited continuing education activity “Webcast - ASCO Direct™ Highlights: 2021 Official Annual Meeting Review", is recorded from the live oncology conference held on 7/24/2021 - 7/25/2021.
If you participated in the live conference titled - ASCO Direct™ Highlights: 2021 Official Annual Meeting Review on 7/24/2021-7/25/2021 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that webinar on 7/24/2021-7/25/2021. However, you may enroll in this activity to review the contents.
REGISTRATION FEES:
This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0.
Healthcare providers ($0.00)
Industry employees - $250 - all industry employees must pay a registration fee even if you are a licensed HCP.
If you are a healthcare provider involved in patient care and you are not employed by the Industry, then you don't pay anything to register for this activity.
If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $1030 per participant.
If you paid to join the live meeting associated with this webcast and wish to register for this enduring material please contact us and we will register you for free.
Target Audience
- Oncologists
- Oncology Nurse Practitioners & Physician Assistants
- Oncology Pharmacists
- Oncology Nurses
- Oncology Residents/Fellow
- Oncology Researchers
Learning Objectives
At the conclusion of the activity, participants will be able to:
- Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors
- Identify side effects, indications, and contra-indications of therapies used to diagnose and treat cancers
- Explain how to effectively manage side-effects associated with cancer treatment
- Review abstracts presented at ASCO® 2021 and discuss their application in clinical settings
This educational activity features recorded videos from the live webinar titled - ASCO Direct Highlights: 2021 Official Annual Meeting Review held July 24-25,2021.
The videos are placed in the following order. Feel free to view the content that is relevant to you.
Participants should claim continuing education credits to the extent of their participation.
Lymphoid malignancies:
Updates in lymphoma – 30 minutes - Dr. Ranjana Advani
Updates in CLL – 30 minutes - Dr. P Venugopal
Rapid fire Q&A – 15 minutes - Dr. David Aboulafia
Hematologic malignancies:
Management of multiple myeloma – 30 minutes - Dr. Shaji Kumar
Acute leukemia – new updates – 30 minutes - Dr. Elihu Estey
Rapid fire Q&A – 15 minutes - Dr. Andrew Cowan
Lung cancer:
Recent updates in NSCLC – 30 minutes - Dr. Jack West
Small cell lung cancer - 30 minutes - Dr. Rafael Santana-Davila
Rapid fire Q&A – 15 minutes - Dr. Joe Rosales
Women’s cancer
Non-metastatic breast cancer – 30 minutes - Dr. Siddhartha Yadav
Metastatic breast cancer - 30 minutes - Dr. Mark Pegram
Gynecologic malignancies – 30 minutes - Dr. Kalyan Banda
Q & A – 15 minutes
General Oncology session
Sarcoma updates – 30 minutes - Dr. Michael Wagner
Shaji Kumar, MDProfessor of Medicine Mayo Clinic | Program ChairShailender Bhatia, MDAssociate Professor University of Washington Medical Oncologist Seattle Cancer Care Alliance | ||
David Aboulafia, MDMedical Oncologist/Hematologist Virginia Mason | Mark Pegram, MDProfessor of Medicine Stanford University | ||
Siddhartha Yadav, MDMedical Oncologist Mayo Clinic | Sakti Chakrabarti, MDAssociate Professor of Medicine Medical College of Wisconsin | ||
Jack West, MDMedical Oncologist City of Hope | Parameswaran Venugopal, MD Professor of Medicine & Director - Section of Hematology Rush University | ||
Ranjana Advani, MDMedical Oncologist Stanford University | |||
Andrew Cowan, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | Cristina Rodriguez, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | ||
Fengting Yan, MDMedical Oncologist Swedish Medical Center | Andrew Coveler, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | ||
Neeraj Agarwal, MDProfessor of Medicine University of Utah, Huntsman Cancer Institute | Rafael Santana-Davila, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | ||
Michael Wagner, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | Kalyan Banda, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | ||
Vyshak Venur, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | Cristina Merkhofer, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | ||
Stacey Cohen, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | Jacob Appelbaum, MD, PhDMedical Oncologist Seattle Cancer Care Alliance | ||
Scott Tykodi, MDAssociate Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | Christina Poh, MDAssistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance | ||
Glynn Gilcrease III, MDAssistant Professor of Medicine University of Utah, Huntsman Cancer Institute | Joseph Rosales, MDMedical Oncologist/Hematologist Virginia Mason | ||
Lindsay Hannan, MDClinical Assistant Professor of Medicine University of Washington Medical Oncologist Seattle Cancer Care Alliance |
Disclosures:
No Members of this activity's planning committee or faculty have any relevant financial relationship with an ineligible entity except for the following faculties. All conflicts have been mitigated.
Shaji Kumar, MD
Research support/Grant: Abbvie, Amgen, BMS, Carsgen, Janssen, KITE, Merck, Astra-Zeneca, Novartis, Roche-Genentech, Takeda, Tenebio
Consulting/Advisory Board participation: (with no personal payments) Abbvie, Amgen, BMS, Janssen, Roche-Genentech, Takeda, KITE, Astra-Zeneca, Bluebird Bio, and (with personal payment) Oncopeptides, Beigene, Antengene
Shailender Bhatia, MD
Research support/Grant to institution: EMD Serono, Merck, BMS, NantKwest, Novartis, Nektar, Exicure, Checkmate Pharma, Xencor
Consultant (advisory board with honoraria): BMS, Sanofi-Regeneron, EMD-Serono, Genentech
Mark Pegram, MD
Consultant: Pfizer, Eli Lilly, Novartis, Genentech/Roche, AstraZeneca
Sakti Chakrabarti, MD
Consultant - HalioDx, QED Therapeutics, DAVA Oncology,
Grant/Research Support - MERCK, Taiho Pharmaceutical, Roche Tissue
Diagnostics, Natera Inc..
Howard Jack West, MD
Consultant: Amgen, AstraZeneca, Genentech/Roche, Merck, Mirati, Regeneron
Speaker Bureau: Merck, AstraZeneca
Andrew Cowan, MD
Research support/Grant: Janssen, Bristol Myers Squibb, Abbvie, Sanofi Aventis, Harpoon
Consultant: Janssen, Abbvie, Cellectra, Sanofi, GSK
Cristina Rodriguez, MD
Research support/Grant: AstraZeneca, Ayala, Bristol Myers Squibb, Cue Biopharma, Kura, Merck
Consultant: Cue Biopharma
Andrew Coveler, MD
Research support/Grant: Actuate, Amgen, Medimmune
Consultant: Novocure, Seagen, Surface
Neeraj Agarwal, MD
Consultant: Astellas, AstraZeneca, Aveo, Bayer, BMS, Calithera, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Foundation Medicine, Genenetech, Janssen, Merck, MEI Pharma, Nektar, Novartis, Pfizer, Pharmacyclics, Seattle Genetics
Rafael Santna-Davila, MD
Consultant: Genentech, Bayer, NGM Biopharmaceuticals, Takeda, Lilly, AstraZeneca, Culinan Oncology, BMS
Research Support to Institution: Bayer, AstraZeneca, Genentech, Lilly, BeyondSPring Pharmaceuticals, ISA Pharmaceuticals, Abbvie
Michael Wagner, MD
Consultant: Adaptimmune, Deciphera
Research support/Grant: Adaptimmune, Deciphera, Athenex, GSK, Inhibrx, Incyte
Vyshak Alva Venur, MD
Consultant: Seagen
Stacy Cohen, MD
Consultant: Natera
Scott Tykodi, MD
Consultant: Exelixis, Merck, BMS, Intellisphere
Research Support/Grant: BMS, Genentech, Pfizer, Nektar Therapeutics, Merck, Exelixis, Jounce Therapeutics
Ranjana Advani, MD
Commercial Interest(s): Agensys, Relationship: Research support/Grant
Commercial Interest(s): Celgene, Relationship: Research support/Grant
Commercial Interest(s): Genentech/Roche, Relationship: Research support/Grant
Consultant: iDMC
Commercial Interest(s): Forty Seven/Gilead, Relationship: Research support/Grant
Commercial Interest(s): Janssen Pharmaceuticals, Relationship: Research support/Grant
Commercial Interest(s): Kura, Relationship: Research support/Grant
Consultant
Commercial Interest(s): Merck, Relationship: Research support/Grant
Consultant
Commercial Interest(s): Millenium, Relationship: Research support/Grant
Commercial Interest(s): Pharmacyclics, Relationship: Research support/Grant
Commercial Interest(s): Regeneron, Relationship: Research support/Grant
Commercial Interest(s): Seattle Genetics, Relationship: Research support/Grant, Please list if you selected other):
Commercial Interest(s): Cytier Therapeutics, Relationship: Research support/Grant
Commercial Interest(s): Incyte, Relationship: Consultant
Commercial Interest(s): Gilead, Relationship: Consultant
Commercial Interest(s): Bristol Myers Squibb/Celgene, Relationship: Consultant
Commercial Interest(s): BeiGene Ltd, Relationship: Consultant
Commercial Interest(s): Daiichi Sankyo, Relationship: Consultant
Commercial Interest(s): Sanofi, Relationship: Other
Commercial Interest(s): Takeda, Relationship: Other: CME
Commercial Interest(s): Karyopharm, Relationship: Consultant
Commercial Interest(s): ADC Therapeutics, Relationship: Consultant
Important Information about Claiming CME for this activity:
If you participated in the live webinar titled - ASCO Direct™ Highlights: 2021 Official Annual Meeting Review on 7/24/2021-7/25/2021 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This is a recorded content from that webinar on 7/24/2021-7/52/2021. However, you can still enroll in this activity and review the contents as needed.
The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.
The Binaytara Foundation designates this enduring activity for a maximum of - 6 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria for up to - 6 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
Nursing Contact Hours: Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6 Contact Hours.
ABSM Maintenance of Certificate Recognition Statement: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to - Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Available Credit
- 6.00 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 0.00 Attendance
- 6.00 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
Price
REGISTRATION FEES:
This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0.
Healthcare providers ($0.00)
Industry employees ($500 + 3% Credit card fee)
If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!
If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $1030 per participant.
If you paid to join the live meeting and wish to register for this enduring material please contact us and we will register you for free.
Cancellation Policy
You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.
Refund Policy
This activity is free for all healthcare providers who are not employees of an ineligible entity.
No refunds will be issued if you have started watching the recorded content.